Failed cancer drug finds success in phase III trial as achondroplasia treatment
A cancer drug that failed in oncology trials has now succeeded in treating achondroplasia, the most common form of dwarfism, and could be on the market next year.
Professor Ravi Savarirayan says more experimental cancer drugs are becoming treatments for rare diseases. A cancer medicine is likely to arrive on the market next year โ not for oncology, but for the most common form of dwarfism. An Australian-led phase III
More from Cuppa
Google's new 'CC' is an AI agent that helps families run their householdsGoogle has relaunched its CC AI agent as a household organiser for families, helping manage schedules, school emails, meal plans and shared to-do lists.
SpaceX to fly more NASA crews to space station under expanded $5.92 billion dealNASA has handed SpaceX a $946 million contract for three more astronaut missions to the International Space Station, extending the partnership through 2030.
Coffee on the nanoscale: Graphene oxide membrane removes half the caffeine while retaining key compoundsAustralian researchers at UNSW have developed a graphene oxide membrane that removes about half the caffeine from already-brewed coffee while keeping its flavour compounds intact.
China extending sea dominion to Batanes?China's Coast Guard is now patrolling waters east of the Philippines' Batanes islands, raising fears Beijing is expanding its maritime claims beyond the South China Sea.
Women and girls pay high price in DR Congo Ebola outbreakWomen and girls make up more than half of confirmed Ebola cases in the DR Congo outbreak, largely because they bear the burden of caring for the sick at home.
Macklemore ticket prices rise amid Ed Sheeran tour falloutMacklemore was dropped from Ed Sheeran's tour after making pro-Palestine comments onstage, and has since announced he will donate his $1 million in tour earnings to Palestinian aid.
UK publisher drops books by David WalliamsHarperCollins UK is dropping David Walliams' entire back catalogue after allegations of harassing female staff, going further than its earlier decision to stop new titles.
Uber ordered to pay $40m to family of woman killed after driver left her on highwayA US jury ordered Uber to pay $40 million to the family of a 23-year-old killed after her driver dumped her and a sick friend on a California highway.